tibolone has been researched along with Cancer of Ovary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Brusselaers, N; Callens, S; Engstrand, L; Simin, J; Tamimi, RM | 1 |
| Altwerger, G; Black, J; Feinberg, J; Menderes, G; Ratner, E; Whicker, M | 1 |
| Løkkegaard, ECL; Mørch, LS | 1 |
| Dyba, T; Koskela-Niska, V; Lyytinen, H; Pukkala, E; Ylikorkala, O | 1 |
| Huang, H; Pan, L; Shen, K; Wen, Y; Wu, M | 1 |
| Neves-E-Castro, M | 1 |
| Chatzigeorgiou, K; Goulis, D; Pantazis, K; Papanicolaou, A; Tarlatzis, BC; Theodoridis, TD; Vavilis, D | 1 |
| Lee, JM; Lee, KB; Park, CY; Yoon, JH | 1 |
| Kimmig, R; Schmidt, M | 1 |
3 review(s) available for tibolone and Cancer of Ovary
| Article | Year |
|---|---|
Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer.
Topics: Administration, Topical; Anabolic Agents; Body Image; Cognitive Behavioral Therapy; Depression; Estrogen Antagonists; Estrogens; Fatigue; Female; Hormone Replacement Therapy; Humans; Lubricants; Menopause, Premature; Norpregnenes; Ovarian Neoplasms; Pelvic Floor Disorders; Physical Therapy Modalities; Phytotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sexuality; Tamoxifen; Testosterone | 2017 |
Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
Topics: Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms | 2008 |
[The benefits and risks of hormonal replacement therapy--an update].
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Dementia; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Meta-Analysis as Topic; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Primary Prevention; Progestins; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors | 2006 |
6 other study(ies) available for tibolone and Cancer of Ovary
| Article | Year |
|---|---|
Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
Topics: Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Estrogens; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Ovarian Neoplasms; Progestins; Prospective Studies; Risk; Sweden | 2020 |
Tibolone and risk of gynecological hormone sensitive cancer.
Topics: Aged; Denmark; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Humans; Incidence; Middle Aged; Norpregnenes; Ovarian Neoplasms | 2018 |
Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Contraceptive Agents, Female; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Finland; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Registries; Risk | 2013 |
The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China.
Topics: Adolescent; Adult; Carcinoma, Ovarian Epithelial; Case-Control Studies; China; Disease-Free Survival; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens; Hormone Replacement Therapy; Humans; Kaplan-Meier Estimate; Menopause, Premature; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Norpregnenes; Ovarian Neoplasms; Postoperative Period; Proportional Hazards Models; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Hormonal replacement therapy in ovarian cancer survivors: a survey among Greek gynecologists.
Topics: Antineoplastic Agents, Hormonal; Attitude of Health Personnel; Diphosphonates; Estrogens; Female; Greece; Gynecology; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Ovarian Neoplasms; Phytoestrogens; Prescriptions; Progestins; Surveys and Questionnaires | 2011 |
The safety of tibolone in epithelial ovarian cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Case-Control Studies; Chi-Square Distribution; Climacteric; Disease-Free Survival; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Multivariate Analysis; Neoplasms, Glandular and Epithelial; Norpregnenes; Ovarian Neoplasms; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2006 |